MEREO BIOPHARMA GROUP PLC SECURITIES FRAUD NOTICE: Berger Montague Informs Mereo BioPharma Group plc (MREO) Investors of Securities Fraud Lawsuit

Philadelphia, Pennsylvania--(Newsfile Corp. - March 2, 2026) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Mereo BioPharma Group plc (NASDAQ: MREO) ("Mereo" or the "Company") on behalf of investors who purchased the American Depositary Shares ("ADS") of Mereo during the period from June 5, 2023 through December 26, 2025 (the "Class Period").Investor Deadline: Investors who purchased Mereo securities during the Class Period may, no later than ...